UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000020837 |
|---|---|
| Receipt number | R000024054 |
| Scientific Title | Effect of Additional pertuzumab for the post treatment in Patients with HER2 positive locally advanced/ metastatic Breast Cancer Who Were Previously Treated with pertuzumab - Phase II study - |
| Date of disclosure of the study information | 2016/02/02 |
| Last modified on | 2019/01/22 19:07:38 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/02/01 22:13:32 | ||
| 2 | Update | 2016/04/29 16:37:46 | Email Name of primary person or sponsor Organization |
|
| 3 | Update | 2016/04/29 17:01:38 | Acronym Acronym |
|
| 4 | Update | 2016/04/29 21:27:41 | Interventions/Control_1 Interventions/Control_1 |
|
| 5 | Update | 2018/09/23 11:59:11 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 6 | Update | 2019/01/22 19:07:38 | Recruitment status |
